We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXJ
2251
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$18K ﹤0.01%
+1,279
New +$17.8K
OFLX icon
2252
Omega Flex
OFLX
$312M
$18K ﹤0.01%
238
+210
+750% +$17.6K
PKOH icon
2253
Park-Ohio Holdings
PKOH
$761M
$18K ﹤0.01%
553
+2
+0.4% +$68
PLAB icon
2254
Photronics
PLAB
$1.93B
$18K ﹤0.01%
2,219
+1,349
+155% +$12K
PRU icon
2255
Prudential Financial
PRU
$41.8B
$18K ﹤0.01%
181
-6,605
-97% -$658K
SLRC icon
2256
SLR Investment Corp
SLRC
$715M
$18K ﹤0.01%
891
+247
+38% +$5.2K
CURO
2257
DELISTED
CURO Group Holdings Corp.
CURO
$18K ﹤0.01%
1,625
+1,004
+162% +$10.7K
HZN
2258
DELISTED
Horizon Global Corporation
HZN
$18K ﹤0.01%
+5,052
New +$16.5K
IIN
2259
DELISTED
IntriCon Corporation
IIN
$18K ﹤0.01%
+785
New +$19.6K
CHAP
2260
DELISTED
Chaparral Energy, Inc.
CHAP
$18K ﹤0.01%
+3,939
New +$19.7K
GHDX
2261
DELISTED
Genomic Health, Inc.
GHDX
$18K ﹤0.01%
+305
New +$18.1K
EMKR
2262
DELISTED
Emcore Corp
EMKR
$18K ﹤0.01%
558
+65
+13% +$2.42K
UN
2263
DELISTED
Unilever NV New York Registry Shares
UN
$18K ﹤0.01%
295
-475
-62% -$28.4K
IMH
2264
DELISTED
Impac Mortgage Holdings Inc.
IMH
$18K ﹤0.01%
5,664
+5,326
+1,576% +$18.4K
ALNT icon
2265
Allient
ALNT
$1.92B
$17K ﹤0.01%
654
-495
-43% -$11.9K
AME icon
2266
Ametek
AME
$58.2B
$17K ﹤0.01%
183
-4,608
-96% -$395K
AMTB icon
2267
Amerant Bancorp
AMTB
$1.13B
$17K ﹤0.01%
+824
New +$14.5K
CPIX icon
2268
Cumberland Pharmaceuticals
CPIX
$117M
$17K ﹤0.01%
2,596
+2,259
+670% +$13.7K
FOX icon
2269
Fox Class B
FOX
$23.9B
$17K ﹤0.01%
470
-7,532
-94% -$273K
GALT icon
2270
Galectin Therapeutics
GALT
$348M
$17K ﹤0.01%
4,033
-3,551
-47% -$15.4K
HACK icon
2271
Amplify Cybersecurity ETF
HACK
$2.91B
$17K ﹤0.01%
+419
New +$16.7K
IAG icon
2272
IAMGOLD
IAG
$10.5B
$17K ﹤0.01%
5,095
-2,424
-32% -$7.07K
IBB icon
2273
iShares Biotechnology ETF
IBB
$9.71B
$17K ﹤0.01%
157
-81
-34% -$8.62K
LNW
2274
DELISTED
Light & Wonder
LNW
$17K ﹤0.01%
853
+218
+34% +$4.51K
PLBC icon
2275
Plumas Bancorp
PLBC
$429M
$17K ﹤0.01%
659
+154
+30% +$3.8K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.